Detalles de la búsqueda
1.
Genome-wide cell-free DNA fragmentation in patients with cancer.
Nature
; 570(7761): 385-389, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31142840
2.
Detailed analysis of metastatic colorectal cancer patients who developed cardiotoxicity on another fluoropyrimidine and switched to S-1 treatment (subgroup analysis of the CardioSwitch-study).
Acta Oncol
; 63: 248-258, 2024 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38698698
3.
Harnessing the Potential of Real-World Evidence in the Treatment of Colorectal Cancer: Where Do We Stand?
Curr Treat Options Oncol
; 25(4): 405-426, 2024 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38367182
4.
First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer Group.
Lancet Oncol
; 24(7): 757-771, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37329889
5.
Time-varying prognostic value of primary tumor sidedness in metastatic colorectal cancer: A population-based study and meta-analysis.
Int J Cancer
; 152(7): 1360-1369, 2023 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36346099
6.
Pembrolizumab in Asian patients with microsatellite-instability-high/mismatch-repair-deficient colorectal cancer.
Cancer Sci
; 114(3): 1026-1036, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36369901
7.
Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer.
N Engl J Med
; 383(23): 2207-2218, 2020 12 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33264544
8.
Survival of Patients with Deficient Mismatch Repair Versus Proficient Mismatch Repair Metastatic Colorectal Cancer Receiving Curative-Intent Local Treatment of Metastases in a Nationwide Cohort.
Ann Surg Oncol
; 30(11): 6762-6770, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37528303
9.
Intersurgeon Variability in Local Treatment Planning for Patients with Initially Unresectable Colorectal Cancer Liver Metastases: Analysis of the Liver Expert Panel of the Dutch Colorectal Cancer Group.
Ann Surg Oncol
; 30(9): 5376-5385, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37118612
10.
Predicting early extrahepatic recurrence after local treatment of colorectal liver metastases.
Br J Surg
; 110(3): 362-371, 2023 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36655278
11.
Work Ability in Patients With Stage I to IV Colon Cancer: Results of the Dutch Prospective Colorectal Cancer Cohort.
Dis Colon Rectum
; 66(1): 50-58, 2023 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34753892
12.
Toxicity and efficacy of chronomodulated chemotherapy: a systematic review.
Lancet Oncol
; 23(3): e129-e143, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35240088
13.
Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study.
Lancet Oncol
; 23(5): 659-670, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35427471
14.
Predictive value of chromosome 18q11.2-q12.1 loss for benefit from bevacizumab in metastatic colorectal cancer: A post hoc analysis of the randomized phase III-trial AGITG-MAX.
Int J Cancer
; 151(7): 1166-1174, 2022 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35489024
15.
Development and external validation of a prediction model for overall survival after resection of distal cholangiocarcinoma.
Br J Cancer
; 126(9): 1280-1288, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35039626
16.
Serum-based measurements of stromal activation through ADAM12 associate with poor prognosis in colorectal cancer.
BMC Cancer
; 22(1): 394, 2022 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35413826
17.
External validation of the MSKCC nomogram to estimate five-year overall survival after surgery for stage I-III colon cancer in a Dutch population.
Acta Oncol
; 61(5): 560-565, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35253593
18.
Stromal-derived interleukin 6 drives epithelial-to-mesenchymal transition and therapy resistance in esophageal adenocarcinoma.
Proc Natl Acad Sci U S A
; 116(6): 2237-2242, 2019 02 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30670657
19.
Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
Lancet Oncol
; 22(5): 665-677, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33812497
20.
Informing metastatic colorectal cancer patients by quantifying multiple scenarios for survival time based on real-life data.
Int J Cancer
; 148(2): 296-306, 2021 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32638384